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Abstract
A history of concussion, particularly repeated injury, has been linked to an increased risk for
the development of neurodegenerative diseases, particularly chronic traumatic encephalop-
athy (CTE). CTE is characterized by abnormal accumulation of hyperphosphorylated tau
and deficits in learning and memory. As yet the mechanisms associated with the develop-
ment of CTE are unknown. Accordingly, the aim of the current study was to develop and
characterize a novel model of repetitive mTBI that accurately reproduces the key short and
long-term functional and histopathological features seen clinically. Forty male Sprague-
Dawley rats were randomly assigned to receive 0, 1 or 3x mTBI spaced five days apart
using a modified version of the Marmarou impact-acceleration diffuse-TBI model to deliver
110G of linear force. Functional outcomes were assessed six and twelve weeks post-injury,
with histopathology assessed twenty-four hours and twelve weeks post-injury. Repetitive
mTBI resulted in mild spatial and recognition memory deficits as reflected by increased
escape latency on the Barnes maze and decreased time spent in the novel arm of the Y
maze. There was a trend towards increased anxiety-like behavior, with decreased time
spent in the inner portion of the open field. At 24 hours and 12 weeks post injury, repetitive
mTBI animals showed increased tau phosphorylation and microglial activation within the
cortex. Increases in APP immunoreactivity were observed in repetitive mTBI animals at 12
weeks indicating long-term changes in axonal integrity. This novel model of repetitive mTBI
with its persistent cognitive deficits, neuroinflammation, axonal injury and tau hyperpho-
sphorylation, thus represents a clinically relevant experimental approach to further explore
the underlying pathogenesis of CTE.
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Introduction
In recent years, awareness of mild traumatic brain injury (mTBI), or concussion, has increased
significantly at both local and international levels. It is particularly common in contact sports
such as American Football (NFL), Australian Rules Football (AFL) and boxing. In the United
States alone, an estimated 1.6–3.8 million sport or recreation related concussions occur each
year, although this number may be much higher given that many individuals with a potential
concussion do not seek further treatment [1]. The incidence of concussion in professional con-
tact sports has also risen in recent years, with 73% of retired professional AFL players reporting
that they experienced at least one concussion over their playing career, with over half reporting
multiple concussions [2].
Concussion is defined as a complex pathophysiological process affecting the brain induced
by traumatic biomechanical forces, caused by either a direct blow to the head, face or neck or
via excessive force elsewhere on the body transmitted to the head [3]. The injury typically
results in the rapid onset of acute neurological dysfunction and clinical symptoms such as loss
of consciousness, dizziness, headache, and photophobia [3, 4]. Although concussion may result
in neuropathological changes, there are typically no abnormalities observed within the con-
cussed brain using standard structural imaging techniques and any clinical symptoms observed
are the result of functional disturbances [3].
TBI, regardless of severity level, involves a complex series of biochemical changes within the
brain involving neurotoxicity, metabolic imbalances and general disruption of ionic and cellu-
lar homeostasis [5]. Most concerning however is the state of vulnerability that these cells enter
following a concussive event, where if another concussion is sustained during the vulnerable
period, the damage to these cells exponentially increases and may become irreversible [6, 7].
However, increasing evidence of a link between repetitive mTBI and emergence of neurodegen-
erative disorders later in life, such as Alzheimer’s disease (AD) and more recently, chronic trau-
matic encephalopathy (CTE) emphasizes the potential danger of multiple concussions.
CTE is thought to be a progressive tauopathy, characterized by the deposition of tau protein
in the form of neurofibrillary tangles (NFTs) within the superficial cortical layers of the frontal
and temporal lobes [8]. It is believed that patients that are believed to be diagnosed with CTE
display signs of short term memory dysfunction, difficulties in higher-order decision making
such as planning and multitasking, apathy, emotional instability and depression [8, 9]. These
clinical representations of CTE are postulated to develop from a progressive loss of neurons
and inclusions of NFTs in the associated functional areas, including the frontal cortex, tempo-
ral lobe and hippocampus [9]. Although there are clinical and pathological signs suggestive of
the presence of CTE within some individuals, the link between repeated mTBI and the later
emergence of this pathology is yet to be fully elucidated [10].
In order to understand the pathophysiology of CTE, appropriate models that accurately rep-
resent key clinical and pathological features of repeated mTBI are required. In order model the
type of brain injury that is currently observed in sports injuries, it has been proposed that a
number of criteria should be met. These include that the head must be struck directly; that the
impacts should occur with high velocity and rapid acceleration of the head, both rotational and
angular [11–13]; that the injuries should be mild enough not to cause more severe injury such
as edema, neuronal damage or hemorrhage [11, 14]; and that long-term manifestations of the
injury should reflect the onset of CTE, including mild cognitive deficits, changes in mood and
the appearance of neuropathological features such as tau phosphorylation [15–17]. The aims of
the current study were to assess the effectiveness of the well characterized Marmarou impact
acceleration model [18] in producing an in vivomodel of repetitive mTBI that will accurately
portray the effects seen clinically.
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Materials & Methods
Animals
All experimental procedures were carried out in accordance with the recommendations in the
Australian Code for the Care and Use of Animals for Scientific Purposes 8th edition (2013),
and approved by the University of Adelaide Animal Ethics Committee (M-2012-225). Forty
male Sprague-Dawley rats were randomized into one of three experimental groups: sham sur-
gery (no injury), single mTBI (1x injury) or repetitive mTBI (3x injuries). Injuries occurred five
days apart over a ten-day period (Table 1), as based on previous work, with this spacing allow-
ing for resolution of the inflammatory response between injuries, as would be seen at two-four
weeks following a human concussion [19]. The study was further divided into two arms: 1) a
12-week behavioral outcome (n = 25) study, encompassing motor and cognitive components;
and 2) examination of histology at 24 hours (n = 15) following final injury or sham surgery.
Induction of Mild Traumatic Brain Injury
Animals were injured using a modified version of Marmarou impact acceleration model of dif-
fuse traumatic brain injury [18] titrated to produce a 110g average linear acceleration force
[20]. Animals were anaesthetized with 5% isoflurane and the skull was exposed via a midline
incision to adhere a stainless steel disc (10mm diameter, 3mm depth) centrally between the
lambda and bregma sutures using a polyacrylamide adhesive. Animals were then secured to a
foam bed (Type E bed foam, Foam to Size) and injury induced via the release of a 450g brass
weight from a height of 1 meter directly onto the steel disc. Previous studies have shown that
this injury produces an average linear acceleration force of 110g [20] which is that typically
observed in human concussive impacts [21]. Following injury, the incision was closed using
sutures, a local anesthetic applied (lignocaine) and the animal allowed to regain consciousness.
Animals not receiving an injury on a scheduled injury day as per Table 1 received all surgical
procedures without undergoing injury. All animals were weighed daily following commence-
ment of the injury schedule.
Functional Outcome Measures
Animals were assessed weekly for motor outcome using the rotarod test [22], while changes in
locomotion, anxiety and spatial memory were assessed at six and twelve weeks post-injury
using the Open Field, Y Maze and Barnes Maze functional outcome tests [23–25].
Rotarod. The accelerating rotarod is widely considered the most sensitive test of motor
function following diffuse TBI [22]. The device consists of a rotating assembly of 18 metal
rods, each with a diameter of 1 mm so as to introduce a grip component to the test, where the
rotational speed of the assembly is gradually increased from 0 to 30 revolutions per minute
over a 2-min period. To establish a baseline measure, animals were pre-trained on the rotarod
to achieve the maximum running time of 120s for a four-day period pre-injury. The duration
in seconds, up to a maximum of 120 secs, was recorded at the point when animals had either
completed the task, clung to the rods for 2 consecutive rotations without actively walking or
Table 1. Injury schedule for single and repetitive mild traumatic brain injury (TBI) animals.
Number of TBI Day 0 Day 5 Day 10
0 (SHAM) NO INJURY NO INJURY NO INJURY
1 NO INJURY NO INJURY INJURY
3 INJURY INJURY INJURY
doi:10.1371/journal.pone.0160220.t001
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had fallen off. At 24 hours following each injury, then every seven days following the final
injury, rats were assessed using the same criteria to determine any loss in motor function.
Open Field. The Open Field test is a common measure of anxiety in rodents [23]. It con-
sists of a 1m x 1m box divided into 10cm x 10cm grids in which the animal is placed in the cen-
ter and allowed to explore freely for five minutes, with the number of squares traversed, as well
as the percentage of inner squares versus outer squares (the peripheral two rows) calculated.
This test is based on the innate curiosity of the rat, where normal, uninjured animals normally
will explore the entire area quite readily, whilst injured animals are anxious and will spend less
time exploring the inner portion of the field.
YMaze. The Y Maze assesses spatial and recognition memory in rodents, again based on
the rodent’s innate curiosity and desire to explore new areas [24]. The three arms are arbitrarily
assigned into start, novel and other arms. The animal is first introduced into the maze with the
novel arm blocked off and allowed to freely explore for three minutes. One hour after the initial
exposure the rat is reintroduced into the maze with all three arms open and allowed to explore
freely for three minutes. This test works on the basis that an uninjured animal will spend more
time exploring the novel arm to which they have not been previously exposed, rather than the
other two arms. In order to remove scent trails the maze was wiped thoroughly with 70% etha-
nol after each trial. The experimenter was not in the room during the trials, with all trials cap-
tured on video. A preference index was calculated as time spent in the novel arm versus time
spent in all three arms and analyzed.
Barnes Maze. The Barnes Maze assesses spatial learning and memory in rodents, taking
advantage of the rodent’s innate behavior to escape from brightly lit open areas [25]. The appa-
ratus consists of a circular maze 1.2m in diameter, with eighteen escape holes (5cm diameter)
placed around the circumference, with an escape box located underneath one of these holes.
An aversive stimulus in the form of a floodlight is introduced to motivate the animal into find-
ing the escape box. The animal is placed in the center of the maze and if the animal discovers
and enters the box within the 3 min test timeframe, the light is switched off and the animal is
returned to its home cage. If the animal fails to find the escape box, or if the animal finds the
escape box but does not enter within the allotted three minutes, it is gently guided to the
box by the experimenter and held there for 20s with the light switched off before being
returned to its home cage. Animals undertook 2 trials, 15 mins apart over a 4 day period.
Escape latency was recorded as the time taken for the animal’s head to enter the escape box,
with the average recorded across the 2 trials per day. Animals failing to successfully locate the
escape box on any given day received the maximum score possible for that trial (180s).
Immunohistochemistry
Following the completion of the 12 week behavioral outcome studies a random subset of ani-
mals (n = 6 per group), and for the histology subset at 24 hours (n = 5 per group), animals were
sacrificed via transcardial injection of 10% buffered formalin. Brains were then removed and
stored in 10% buffered formalin for 24 hours. At this stage all brains were examined for evi-
dence of hemorrhage, contusions or overt edema. They were then sectioned into 11 x 2mm
areas using a rodent brain matrix (Kopf) and embedded in paraffin wax. For each animal a sec-
tion was cut from the region −4.5 mm from the bregma, as this was located directly underneath
the impact site. Immunohistochemical staining for neuroinflammation (IBA1, rabbit poly-
clonal, 1:20,000, Wako Pure Chemical Industries, 019–19741), axonal injury (amyloid precur-
sor protein (APP), mouse monoclonal, 1:1000, Novocastra, NCL-APP) and phosphorylated
tau (AT180, mouse monoclonal, 1:1000, Thermo Fisher, MN1040) was undertaken. Prepared
sections were dewaxed and endogenous peroxidases blocked with 0.01% hydrogen peroxide/
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methanol. Slides were then placed into a citrate retrieval solution and microwaved at 100°C for
10 minutes prior to blocking non-specific binding using normal horse serum and application
of the appropriate primary antibody for overnight incubation at room temperature. Secondary
antibody (Vector Laboratories, anti-mouse/anti-rabbit, 1:250) was then applied for 30 minutes,
followed by streptavidin peroxidase conjugate (Sigma-Aldrich, 1:1000) for 1 hour. Bound anti-
body was detected via application of 3,3’-Diaminobenzidine (DAB, Sigma-Aldrich, D-5637)
followed by counterstaining with hematoxylin.
All slides were scanned using digital Nanozoomer technology (Hamamatsu) and viewed
using NDP view software (Hamamatsu). Sections stained with AT180 and IBA1 were examined
in 1mm2 cortical areas directly beneath the impact site in each sample. Phosphorylated tau,
identified as dark brown staining of the cytoplasm, was analyzed by counting the number of
AT180 positive cells within the selected region of interest. IBA1 staining was assessed by count-
ing the number of resting microglia, with lighter staining cell bodies and extended processes, as
well as activated microglia, which had dark staining cell bodies and retracted, dark processes,
and then calculating the ratio of resting versus activated microglia within the selected region in
interest. APP staining was assessed using a rating scale for level of intensity in cortical, hippo-
campal (CA2) and thalamic regions. All histological assessments were undertaken by two inde-
pendent observers blinded to the treatment groups.
Statistical Analysis
All data were analyzed using GraphPad Prism1 statistical software. All immunohistochemical
analyses excluding APP scoring, Barnes Maze and Rotarod were evaluated using a one-way
analysis of variance (ANOVA) followed by Tukey post-hoc analysis. APP scoring data were
evaluated using a Kruskal-Wallis test with Dunn’s post-hoc analysis. Barnes Maze and
Rotarod data were evaluated using a repeated measures two-way ANOVA followed by Tukey
post-hoc analysis. A p value of p<0.05 was considered significant. All results are expressed as
mean ± SEM.
Results
There were no adverse acute effects following induction of injury, with animals recovering well
with an average of 0–10g of weight loss observed at 24 hours post-injury that was regained
within 2–5 days.
Functional Outcome
Cognition. At 6 weeks post-injury, Barnes Maze testing on Day 1 showed increased
latency in the acquisition phase in 3x mTBI (107.85±28.15, p<0.001) and 1x mTBI (67.17
±14.73, p<0.01) animals when compared to shams (27.61±6.05) (Fig 1A). Similar results in
3mTBI animals were observed at 12 weeks post-injury in the acquisition phase, with a signifi-
cant difference observed on day 1 testing between 3x mTBI (34.64±7.58) and sham (22±4.03)
animals (p<0.05), whilst no increase in latency was observed in 1x mTBI (24.67±5.81) animals
(Fig 1B). All injury groups returned to sham levels by day 2 of testing and remained at sham
levels at both the 6 and 12 week time-points post-injury.
In the Y maze, there were no significant differences between groups at 6 weeks post-injury
(Fig 1C). However at 12 weeks post-injury 3x mTBI animals demonstrated a significant
decrease in spatial memory as shown by a decrease in preference index (p<0.05), compared to
sham and 1x mTBI groups (Fig 1D).
Open Field. In the Open Field, 3x mTBI animals demonstrated a significant decrease
(p<0.05) in total line crossings at 6 weeks post-injury (288.43±25.4), as did the 1x mTBI
Acute and Chronic Changes in a Novel Repetitive Mild TBI Model
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animals (314.33±19.91) when compared to sham animals (393.56±27.8) (Fig 2A). Comparable
results were also observed at 12 weeks post-injury in the 3x mTBI group, with a significant
decrease (p<0.05) in open field exploration time (158.5±43.6) compared with sham animals
(293.67±30.12) (Fig 2B). However, there were no differences observed between 1x mTBI ani-
mals and sham or 3x mTBI animals at this time point.
There were no differences in the percentage of inner squares versus total exploration of the
open field at 6 weeks injury (Fig 2C). However at 12 weeks post-injury a significant group effect
was found via one-way ANOVA (p<0.05), with post-hoc analysis reporting a trend between
the sham and 3x mTBI groups (p = 0.09), with sham animals spending 7.2±2.5% of their time
in the inner part of the field compared to 4.5±2.1% in 3x mTBI animals. 1x mTBI animals were
similar to shams, with 8.1±3.1% of time spend in the inner part of the field, such that they were
significantly different to 3x mTBI animals (p<0.05) (Fig 2D).
Fig 1. Behavioral Assessment post-injury. Barnes Maze acquisition phase trials at 6 weeks (A) and 12 weeks (B) post-injury. Y Maze testing at
6 weeks (C) and 12 weeks (D) post-injury (*p<0.05, **p<0.01 compared to sham animals, ##p<0.01, #p<0.05 compared to 1x mTBI animals,
Sham, 1 x mTBI n = 9; 3x mTBI n = 7).
doi:10.1371/journal.pone.0160220.g001
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Motor Outcomes. No significant differences in gross motor function were observed
between the various groups over the 12 week rotarod monitoring period (Fig 3), with all groups
maintaining their baseline times (120 seconds) over the complete testing period.
Gross Neuropathology
There were no gross pathological changes in the form of lesions, hemorrhage, cerebral edema
or overt tissue loss observed in the 3x mTBI groups compared to shams (Fig 4).
Immunohistochemistry
Analysis of AT180-positive neurons within the cortex at 24 hours after injury showed a signifi-
cant increase (p<0.01) in AT180 immunoreactivity within the cytoplasm of cells within the
cortex in 3x mTBI (330.2±58.63) animals compared to sham (88.8±38.14) and 1x mTBI (61.25
±28.77) animals (Fig 5A–5C and 5G). Although there was a decrease in overall number of
AT180 positive cells, 3x mTBI animals still had a significant elevation at 12 weeks post-injury
Fig 2. Open Field.Number of total line crossings 6 weeks (A) and 12 weeks (B) post-injury, and % of inner square line crossings compared to the total
number at 6 weeks (C) and 12 weeks (D) post-injury. (*p<0.05 compared to sham, #p<0.05 compared to 1x mTBI animals; Sham, 1 x mTBI n = 9; 3x
mTBI sham, 1 x mTBI n = 9; 3x mTBI n = 7)
doi:10.1371/journal.pone.0160220.g002
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(89.58±7.81) compared to 1x mTBI (45.63±10.39; p< 0.01) and sham animals (5.33±4.40;
p<0.001) (Fig 5D–5F and 5H)
Analysis of microglial morphology in the cortex directly beneath the impact site at 24 hours
post-injury (Fig 6A–6C) showed a significant increase in activated microglia in the 3x mTBI
animals (32.17±5.97) compared to sham (17.71±2.88; p<0.001) and 1x mTBI animals (26.39
±1.39; P<0.01) (Fig 5G). At 12 weeks post-injury (Fig 5D–5F) increased microglial activation
was still evident in 3x mTBI animals (36.46±3.05) compared to shams (24.08±2.62; p<0.05)
(Fig 5H). However, a significant increase (p<0.05) was also observed in the 1x mTBI group
(34.12±2.15) at 12 weeks post-injury.
Fig 3. Motor Assessment post-injury.Weekly rotarod assessments showing no significant changes in motor function over the 12 week
monitoring period in all groups (Sham, 1 x mTBI n = 9; 3x mTBI n = 7).
doi:10.1371/journal.pone.0160220.g003
Fig 4. Gross Neuropathology.Gross pathology of representative rodent brains showing no lesions,
hemorrhage, edema or overt tissue loss in the 3x mTBI animals compared to sham animals.
doi:10.1371/journal.pone.0160220.g004
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Significant increases (p<0.05) in APP immunoreactivity were observed at 12 weeks post-
injury in 3x mTBI animals in cortical and thalamic regions, as well as the CA2 region of the
hippocampus (Fig 7). 1x mTBI animals only showed a slight increase in APP immunoreactivity
in the cortex, but not the thalamus or hippocampus. No changes were observed at 24 hours
post-injury (S1 Fig).
Fig 5. Tau Immunoreactivity post-injury.Representative images of AT180 staining within the cortex at 24 hours and 12 weeks after injury.
Darker AT180 staining around cell bodies was noted at 24 hours post-injury in 3x mTBI animals (C) compared to sham (A) and 1x mTBI
animals (B). Amount of AT180 immunoreactivity at 12 weeks post-injury was still increased in 3x mTBI (F) and 1x mTBI (E) compared to
sham (D). This was confirmed with a count of AT180 positive cells (G-H) (***p<0.001, **p<0.01 compared to sham; ##p<0.01 compared to
1x mTBI n = 5 for 24 hour time point, n = 6 for 12 week time point)
doi:10.1371/journal.pone.0160220.g005
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Fig 6. Microglial Immunoreactivity post-injury.Representative images of IBA1 staining in the cortex at 24 hours and 12 weeks after injury.
At 24 hours post injury, increased numbers of activated microglia compared to resting were observed in 3x mTBI animals (C) compared to both
sham (A) and 1x mTBI (B) groups At 12 weeks both 1x mTBI (E) and 3x mTBI (F) injury groups showing an increase in microglial activation
compared to shams (D). This was confirmed via quantification determining the % of activated microglia (G). (***p<0.001, *p<0.05 compared
to sham, ##p<0.01 compared to 1x mTBI, n = 5 for 24 hour time point, n = 6 for 12 week time point).
doi:10.1371/journal.pone.0160220.g006
Acute and Chronic Changes in a Novel Repetitive Mild TBI Model
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Discussion
The current study characterizes a model of repetitive mTBI that replicates key functional and
histological features of clinical injury. We have demonstrated that a modified version of the
Marmarou impact-acceleration model, with three mild injuries given five days apart, results in
Fig 7. Changes in APP expression 12 weeks post-injury.Representative images of APP staining in the cortex, thalamus and
CA2 region of the hippocampus in animals at 12 weeks post-injury. Increased APP immunoreactivity was observed across 3x mTBI
animals (G-I, L) compared to sham (A-C, J) and 1x mTBI animals (D-F, K) (**p<0.01, *p<0.05 compared to sham, n = 6)
doi:10.1371/journal.pone.0160220.g007
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an increase in tau phosphorylation within cortical neurons in both the acute and chronic
phases of injury, long-term changes in axonal pathology, as well as persistent neuroinflamma-
tion. These histological changes were associated with the development of deficits in spatial
learning and memory, as seen in the Barnes Maze and the Y Maze, as well as a trend towards
increased anxiety, with less time spent in the inner portion of the Open Field. Although
decreased locomotor activity was noted on the Open Field, no deficits were observed in the
rotarod, indicating that no gross motor deficits were present. There were no signs of overt tis-
sue loss, contusion, edema or hemorrhage, as would be expected of a concussive injury, which
typically produce no lesions that can be seen via standard imaging [26].
Appropriate and relevant experimental animal models are key to allow an understanding of
the pathophysiology of the repeated injury and to allow translation of data to human patients
[27]. To facilitate this a variety of animal models are required to model different aspects of the
disease process, such as the types of forces used to generate a concussion. An advantage of this
model is that it incorporates biomechanical criteria that have been recognized as being key
when developing an experimental model of repetitive mTBI, namely that the head is struck
directly with high velocity causing rapid acceleration of the head [11–13]. This generates
approximately 110g of average linear force [20, 21], similar to the reported injury threshold
required to produce a concussion in a human of 90g of linear acceleration force [21]. Further-
more the impact not only generates linear forces, but also rotational and angular forces [20,
21], similar to what is observed in sports injury [28]. Rotational forces are thought to be partic-
ularly important, as they generate shear strain, which is proposed to be the likely mechanisms
for tissue damage following a concussion [12]. This differs from some of the pre-existing mod-
els, such as lateral fluid percussion [29] and controlled cortical impact [30], which generate a
predominantly focal lesion, and involve restrictions of head movement, typically within a ste-
reotactic frame.
A limitation of any small rodent model is that the rodent brain has structural differences
compared to the human brain, as it is lissencephalic rather than gyrencephalic [31]. This is sig-
nificant given that the forces associated with TBI are focused at the base of the sulci [32], where
tau accumulation is most prominent in CTE [33], whereas in rodent models these forces are
localized to the superficial cortical layers [32]. Furthermore there are slight differences in tau
protein between rodents and human tau, with human tau having a much higher propensity to
aggregate than the rodent form [34]. Despite these limitations pre-clinical models are still able
to provide valuable insights into the development of neurodegeneration following repeated
concussion. Of note this is one of the few models to date that have reported sub-chronic persis-
tent increases in phosphorylated tau in non-transgenic animals following repeated concussion
(reviewed in [27]), highlighting its relevance as a pre-clinical model of CTE.
Importantly this impact-acceleration model of repetitive mTBI also produces behavioral
changes, including anxiety and memory deficits, similar to those seen following repeated con-
cussion. A retrospective study of retired NFL players found that those with a self-reported his-
tory of 3 or more concussions during their playing career had a fivefold prevalence of mild
cognitive impairment compared to those without a previous concussion [35]. Although CTE is
currently a post-mortem diagnosis, correlation of suspected cases with their medical history
and next of kin interviews, has produced a summary of symptoms suspected to be associated
with the disease. Early symptoms are thought to include short-term memory loss, emotional
lability and apathy, with progression to more profound cognitive deficits as the disease pro-
gresses [9, 36].
These functional changes are associated with key histopathological changes, included
increases in hyperphosphorylated tau, neuroinflammation and axonal injury. Increases in
phosphorylated tau both in the acute and chronic stages of injury are seen in the repetitive
Acute and Chronic Changes in a Novel Repetitive Mild TBI Model
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mTBI animals. Tau is a microtubule-associated protein that is involved with providing struc-
tural support to neuronal cells within the CNS [37]. The ability of tau to bind to the microtu-
bules is maintained by its level of phosphorylation. If tau becomes hyperphosphorylated, the
ability to stimulate microtubule assembly is inhibited [38], leading to detachment of the hyper-
phosphorylated tau from the microtubules which makes it prone to self-aggregation and poly-
merization [39]. This leads to the formation of tau oligomers which can further aggregate to
form paired helical filaments (PHFs) which then assemble to form neurofibrillary tangles
(NFTs) as seen in AD and CTE [40, 41]. TBI, particularly repeated concussion, has been shown
to influence tau hyperphosphorylation both pre-clinically and clinically [42–45]. Human
serum analysis following mTBI has also shown increased levels of phosphorylated tau 6 hours
post injury, suggesting that these processes can occur early within the disease process [46]. Of
note this alteration in tau dynamics may contribute to secondary injury following TBI. A study
by Gerson et al. (2016) demonstrated that TBI-derived tau oligomers worsened cognition and
accelerated pathology development when injected into the hippocampi of mice overexpressing
human tau [47]. Furthermore complete ablation or partial reduction of tau prevented deficits
in spatial memory and learning on the Barnes Maze, with a decreased latency to the target fol-
lowing repeated mild frontal impact [48].
Another key feature seen following repeated concussion is a persistent neuroinflammatory
response. Specifically, the present study found that repetitive mTBI increased the expression
of activated microglia in both the acute and chronic phases of injury. Although it is widely
thought that the inflammatory changes observed in mTBI are completely reversible with symp-
toms typically resolving with time, the synergistic effect of repetitive mild injuries over a short
amount of time exacerbates this inflammatory response [5, 49, 50]. As such, there is the poten-
tial for an exponential increase in the inflammatory cascade following mTBI [5] and for the
neuroinflammatory response to persist chronically. Increases in chronic neuroinflammation
have been observed in the brains of young athletes exposed to repetitive mTBI and displaying
CTE-like pathologies post-mortem [51]. Neuroinflammation following TBI has also been
implicated in the pathogenesis of other neurodegenerative disorders including Alzheimer’s dis-
ease [52], with this neuroinflammation not resolving for years following the initial insult [53].
Other existing animal models of repetitive mTBI have also reported increases in neuroinflam-
mation following injury, with increased GFAP reactivity and serum levels of the pro-inflamma-
tory cytokine interleukin-6 (IL-6) observed in a mouse weight drop model [54], while increases
in microglial activation have been reported in a fluid percussion injury model of repetitive
mTBI [19].
The changes in axonal integrity observed long-term are also worth noting given that axonal
injury is present in many other models of repetitive mTBI [27, 55] and in human clinical cases
[56, 57]. Axonal injury is thought to play a key role in promoting abnormal tau phosphoryla-
tion, and the high strain placed on axons in TBI means that tau proteins behave more rigidly
than usual. This may inhibit the ability of adjacent microtubules to slide past each other in
response to axonal stretching, resulting in the subsequent rupture [58]. As tau becomes
unbound from the microtubule it facilitates phosphorylation at disease related sites [59–62],
and promotes aggregation into oligomers and NFTs [63]. Although changes in axonal integrity
were observed within the cortical, thalamic and hippocampal regions in this model, further
investigation into specific regional differences, particularly within the hippocampus, is war-
ranted. Further investigation into acute and chronic changes in synaptic transmission and other
markers of axonal integrity will also further elucidate the extent of these disease processes, par-
ticularly within the acute phase where in the present study, no changes were observed.
It is important to note that there were transient changes observed in the single injury mTBI
group, both behaviorally and pathologically. This is consistent with data from clinical studies
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suggesting that patients with a single mTBI show increased depressive and anxiety-like symp-
toms as well as global brain atrophy, particularly in the white matter regions of the cingulum
and cingulate gyrus, up to one year post-injury [64]. The most common symptoms observed
clinically following a single mTBI include cognitive deficits in the acute stage, typically resolv-
ing within months of the initial injury [65]. Given the prevalence of post-concussive symptoms
such as headache persisting for weeks to months following a single injury, the data presented
within this study and others suggest that a single mTBI is enough to cause long term pathologi-
cal changes within the brain [66]. Animal models have demonstrated that a single mTBI can
acutely induce neurodegenerative and neuroinflammatory changes that increase with injury
severity, and that this is intensified with repeated trauma [67–69]. This suggests that although
a single injury is enough to cause some acute and chronic changes, repetitive injuries appear to
exacerbate these processes.
In conclusion, this study characterizes a clinically relevant, in vivomodel of repetitive mTBI
that produces the key short- and long-term pathological and functional changes observed in
clinical concussive injury, and the typical hallmarks of progressive CTE. Accordingly, this
model of repetitive impact-acceleration mTBI represents a useful experimental approach to
explore the underlying pathogenesis of neurodegeneration following repeated concussion, and
to develop potential therapies.
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